SANN — Santhera Pharmaceuticals Holding AG Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣110.97m
- CH₣150.80m
- CH₣7.47m
Annual cashflow statement for Santhera Pharmaceuticals Holding AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -53.9 | -18.4 | -67.5 | -54.7 | -70.6 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 7.26 | 7.32 | 2.34 | -19.4 | 4.18 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5 | 8.9 | 14.5 | 33 | 26.7 |
| Change in Other Assets | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -37.9 | 2.6 | -43.5 | -37.4 | -29.8 |
| Capital Expenditures | -21.6 | -0.229 | -0.034 | -0.015 | -3.96 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 15.7 | 3.02 | 1.6 | 0.084 | 0.024 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.91 | 2.79 | 1.56 | 0.069 | -3.93 |
| Financing Cash Flow Items | -1.74 | -1.94 | -0.317 | -5.83 | -0.389 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.6 | 4.13 | 23.1 | 46 | 14 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -23.2 | 9.39 | -18.9 | 8.8 | -19.9 |